Research Topics
| J T CoxSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Reducing the burden of cervical cancer and HPV-related diseases through vaccination. IntroductionJ Thomas Cox
Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
Curr Opin Obstet Gynecol 18:s3-4. 2006- Management of women with cervical cytology interpreted as ASC-US or as ASC-HJ Thomas Cox
Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
Clin Obstet Gynecol 48:160-77. 2005 - Extensive condyloma acuminata treated with imiquimod 5% cream: a case reportJ T Cox
Department of Student Health Service, University of California at Santa Barbara, CA 93106, USA
Clin Exp Dermatol 28:51-4. 2003..Minor inflammatory changes were observed during treatment; however, no significant pain was by reported the patient. No recurrences were reported during 2 years of follow-up... - The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?J Thomas Cox
Gynecology Clinic, Health Services, University of California, Santa Barbara, California 93106, USA
Curr Opin Obstet Gynecol 18:s5-s13. 2006..The epidemiology of HPV infection and a brief introduction to the natural history of HPV infection will be presented here... - Management of women with cervical cancer precursor lesionsJ Thomas Cox
Gynecology Clinic Health Services, University of California, Santa Barbara, CA 93110, USA
Obstet Gynecol Clin North Am 29:787-816. 2002..Until that time, understanding all the issues involved in expectant and in active management of cervical HPV-induced lesions will help provide women with the best care possible... - Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practiceJ Thomas Cox
Women s Clinic, Health Services, University of California, Santa Barbara, CA, USA
J Natl Compr Canc Netw 2:597-611. 2004..The gain in sensitivity, apparent cost-effectiveness, and advantage of having a representative specimen for ancillary testing, support the use of LBC... - Using imiquimod for genital warts in female patientsJ Thomas Cox
Student Health Service, University of California, Santa Barbara, California 93106, USA
J Womens Health (Larchmt) 13:265-71. 2004..A reduction in viral load is observed following treatment. Low recurrence rates compared to other treatment modalities may be due to the stimulation of the cell-mediated immune response by imiquimod... - Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou managementJ Thomas Cox
University of California, Santa Barbara, CA, USA
Obstet Gynecol Surv 61:S15-25. 2006..Thus, when used properly, HPV testing may reduce morbidity and mortality and do so in a cost-effective manner... - The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursorsJ Thomas Cox
Gynecology Clinic Health Services, University of California, Santa Barbara, CA 93106, USA
Arch Pathol Lab Med 127:950-8. 2003..The data and the recommendations for the management of ASC-US, ASC cannot exclude high-grade squamous intraepithelial lesion, and LSIL are discussed... - Management of precursor lesions of cervical carcinoma: history, host defense, and a survey of modalitiesJ Thomas Cox
Gynecology Clinic, Health Services University of California, Santa Barbara, CA 93106, USA
Obstet Gynecol Clin North Am 29:751-85. 2002..Of all human cancers, only cervical cancer, once the second most common cancer among women, stands on the threshold of being virtually eliminated... 
History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening resultsJ Thomas Cox
Women s Clinic, University of California Santa Barbara, 93106, USA
J Clin Virol 45:S3-S12. 2009..zur Hausen's discovery to its present eminent role in both primary cervical cancer screening and abnormal Pap management...- Management of atypical squamous cells of undetermined significance and low-grade squamous intra-epithelial lesion by human papillomavirus testingJ T Cox
Gynecology Clinic, Health Services, Bldg. 588, University of California at Santa Barbara, 93106, USA
Best Pract Res Clin Obstet Gynaecol 15:715-41. 2001.... - Epidemiology and natural history of HPVJ Thomas Cox
Gynecology and Colposcopy Clinic Student Health Service, University of California, Santa Barbara, USA
J Fam Pract . 2006..If implemented widely, vaccination against HPV promises to dramatically reduce HPV-associated morbidity and mortality... 
Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24Gaea Moore
University of California Davis, Sacramento, The Permanente Medical Group, Oakland, CA, USA
J Low Genit Tract Dis 14:97-102. 2010....- Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsyJ Thomas Cox
University of California, Santa Barbara, USA
Am J Obstet Gynecol 188:1406-12. 2003..This risk does not vary meaningfully by initial distinction of histologic CIN grade 1 from negative colposcopy and biopsy... - Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotypingBrandon J LaMere
Regional Laboratory, Kaiser Permanente Northern California, Berkley, CA, USA
J Virol Methods 151:298-300. 2008..Six-month frozen storage of cervical specimens at alkaline pH had little impact on testing for HPV genotypes among hc2-positive women using this HPV genotyping method... - Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)Mark E Sherman
Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7374, USA
J Natl Cancer Inst 94:102-7. 2002..Considering age or viral load could improve colposcopy triage... - 2001 Consensus Guidelines for the management of women with cervical cytological abnormalitiesThomas C Wright
Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404, P and S Bldg, 630 W 168th St, New York, NY 10032, USA
JAMA 287:2120-9. 2002..To provide evidence-based consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors... - Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screeningThomas C Wright
Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404 P and S Building, 630 West 168th Street, New York, NY 10032, USA
Obstet Gynecol 103:304-9. 2004..If test results of either are abnormal, colposcopy should then be performed. This guidance should assist clinicians in utilizing HPV DNA testing in an effective manner, while minimizing unnecessary evaluations and treatments... - American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursorsDebbie Saslow
Cancer Control Science Department, American Cancer Society, Altanta, GA, USA
CA Cancer J Clin 57:7-28. 2007..They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed... - Chapter 7: Achievements and limitations of cervical cytology screeningHenry C Kitchener
Academic Unit of Obstetrics and Gynaecology, University of Manchester, St Mary s Hospital, Whitworth Park, Manchester, UK
Vaccine 24:S3/63-70. 2006..The increasing rate of human papillomavirus (HPV) testing and the prospect of prophylactic vaccination will change the way cervical cytology is used, possibly giving way to HPV testing as the primary test in secondary prevention... - Advances in prevention of cervical cancer and other human papillomavirus-related diseasesIan H Frazer
University of Queensland, Center for Immunology and Cancer Research, Brisbane, QLD 4072, Australia
Pediatr Infect Dis J 25:S65-81, quiz S82. 2006 - Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collectionDiane Davis Davey
Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA
J Low Genit Tract Dis 12:71-81. 2008..To provide updated management guidelines according to cervical cytology specimen adequacy and techniques to optimize adequacy based on literature review and expert opinion... - An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS)Philip E Castle
Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
Obstet Gynecol 111:847-56. 2008.... - ASCCP patient management guidelines: Pap test specimen adequacy and quality indicatorsDiane D Davey
Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, USA
Am J Clin Pathol 118:714-8. 2002..The management guidelines will help promote optimal and uniform follow-up of women according to Pap test specimen adequacy... - Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytologyPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
Obstet Gynecol 112:637-45. 2008..To examine the predictors of histologic confirmation of high-grade squamous intraepithelial lesion (HSIL) cytology occurring in follow-up of young women originally referred into a trial because of less severe cytology... - 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasiaThomas C Wright
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, USA
Am J Obstet Gynecol 189:295-304. 2003.... - HPV prevention and the promise of the new vaccinesStephen Allred
Oregon Adult Immunization Coalition Portland, USA
J Am Acad Nurse Pract 18:1-11. 2006